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DNA methylation plays a critical role in the regulation of gene expression. Global DNA methylation 
changes occur in carcinogenesis as well as early embryonic development. However, the current 
methods for studying global DNA methylation levels are invasive and require sample preparation. 
the present study was designed to investigate the potential of Raman microspectroscopy and Raman 
imaging as non-invasive, marker-independent and non-destructive tools for the detection of DNA 
methylation in living cells. To investigate global DNA methylation changes, human colon carcinoma 
HCT116 cells, which were hypomorphic for DNA methyltransferase 1, therefore showing a lower global 
DNA methylation (DNMT1−/− cells), were compared to HCT116 wildtype cells. As a model system for 
early embryogenesis, murine embryonic stem cells were adapted to serum-free 2i medium, leading to 
a significant decrease in DNA methylation. Subsequently, 2i medium -adapted cells were compared to 
cells cultured in serum-containing medium. Raman microspectroscopy and imaging revealed significant 
differences between high- and low-methylated cell types. Higher methylated cells demonstrated higher 
relative intensities of Raman peaks, which can be assigned to the nucleobases and 5-methylcytosine. 
principal component analysis detected distinguishable populations of high- and low-methylated 
samples. Based on the provided data we conclude that Raman microspectroscopy and imaging are 
suitable tools for the real-time, marker-independent and artefact-free investigation of the DNA 
methylation states in living cells.
DNA methylation and de-methylation are involved in gene expression, disease mechanisms and reactions to 
environmental substances. It is assumed that the cellular memory is mainly inherited by DNA methylation1. 
In the DNA methylation process, methyl groups are added to cytosine within CpG dinucleotides. The reaction 
is catalyzed by DNA methyltransferases (DNMT)2,3. There are three catalytically active DNMTs in mammali-
ans. DNMT1 maintains methylation patterns by methylating the newly synthesized DNA strand. DNMT3a and 
DNMT3b are required for de novo DNA methylation4–6. As methylation of promotor regions typically represses 
gene transcription, most of the DNA methylation-related consequences are genomic imprinting and inactivation 
of the X chromosome in female mammals7. Early embryogenesis is marked by dramatic changes in DNA meth-
ylation. After fertilization, DNA methylation in the genome becomes erased over several DNA replication cycles 
involving both active and passive demethylation8. Around implantation, DNMT3a and DNMT3b are expressed 
at high levels to form the normal embryonic methylation patterns9. In the blastocyst stage, high global levels of 
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DNA methylation are detected10. Tracking of these massive changes in global DNA methylation could provide 
new insights about early embryogenesis. After the blastocyst status, the global DNA methylation levels do not 
dramatically change any more during differentiation11–13. However, it was shown that during carcinogenesis, in 
most cancers, a site-specific DNA hypermethylation and a global DNA hypomethylation takes place14–16. In the 
case when promotors of tumor suppressor genes get hypermethylated, the genes are switched off17,18. Global 
hypomethylation in turn leads to genome instability and activation of transposable elements and oncogenes17. It 
has been estimated that 70% of all cancers lead to a reduced global DNA methylation, 18% with no change, and 
12% with an increased DNA methylation relative to the adjacent normal tissue19. This overall change of DNA 
methylation could serve as a valid biomarker for cancer.
There are various approaches to detect and analyze global DNA methylation. A well-established method is 
immunofluorescence (IF) staining based on the use of an anti-5-methylcytosine (5mC) antibody and a secondary 
antibody labeled with a fluorescent dye. The method offers a straightforward visualization of methylated DNA20. 
Furthermore, to study global DNA methylation, an enzyme-linked immunosorbent assay (ELISA) based on 
anti-5mC can be performed. Liquid chromatography-mass spectrometry is also commonly used, yet it requires 
sample preparation and expensive machines to measure the DNA methylation level21. One of the currently most 
widely used techniques to assess DNA methylation is the bisulfite conversion. The DNA is treated with sodium 
bisulfite, which deaminates non-methylated cytosines, converting them into uracils, whereas the treatment does 
not change methylated cytosine22. By comparing the sequences of converted and unconverted DNA, it is possible 
to identify methylated sites. However, all these methods are invasive and potentially create artifacts as they require 
fixation and staining procedures, cell lysis or DNA isolation. So far, there is no appropriate method established 
that allows the online monitoring of global DNA methylation changes in living cells.
A promising tool for online monitoring of living cells and tissues is Raman microspectroscopy as it is a 
non-invasive and marker-independent technique based on light scattering of the illuminated material23. In the 
last decade, Raman spectroscopy has become a method of interest for the field of biomedical research24,25. It 
is a time-saving alternative to other methods investigating biological systems such as fluorescence imaging26. 
Moreover, it allows the analysis of biological processes within living cells. The Raman measurement obtains sig-
nals from proteins, lipids, nucleic acids, carbohydrates and inorganic crystals, which enables to identify and dis-
tinguish cell phenotypes and tissues based on their individual biochemical signature23. The detection of DNA 
methylation using Raman microspectroscopy is not yet established. Some studies investigating DNA methylation 
were performed using surface-enhanced Raman spectroscopy (SERS)27–29. However, no investigations on living 
cells have been performed to date.
In the present study, we used Raman microspectroscopy and principle component analysis (PCA) to identify 
Raman shifts that can indicate global DNA methylation changes in living cells. Two cell types that differ in their 
global DNA methylation level were measured and compared with each other. Genetic modified human colon can-
cer cells that are DNMT1 hypomorph (DNMT1−/− cells) were compared to HCT116 wildtype (WT) cells30. The 
DNMT1−/− cells still retain some DNMT1 activity, yet much reduced, leading to a decreased genome wide meth-
ylation level. As a model system to investigate global DNA methylation changes in early embryogenesis, murine 
embryonic stem cells (mESC) were utilized. mESCs were cultured in serum-containing medium or they were 
adapted to serum-free 2i medium, leading to a significant decrease in DNA methylation31. The aim of the study 
was to investigate if Raman microspectroscopy and imaging are capable to detect the different global DNA meth-
ylation levels in both cell types. IF staining and 5mC ELISA were used to quantify the global DNA methylation in 
the cells. These routine methods served as reference in order to verify the results from the Raman measurements.
Results
5mC and methylated DNA show significantly increased Raman bands. Before measuring DNA 
methylation within cells, cytidine and 5mC as well as methylated and non-methylated DNA standards were inves-
tigated with Raman microspectroscopy (Suppl. Fig. 1). The Raman spectra of 5mC and methylated DNA revealed 
increased signals in the region of 1331–1335 cm−1 (Suppl. Fig. 1a, b). Furthermore, methylated DNA showed sig-
nificantly increased Raman bands at 1335 cm−1 (p < 0.05), 1379 cm−1 (p < 0.05) and 1579 cm−1 (p < 0.01) (Suppl. 
Fig. 1c).
DNMT1-deficient cells reveal a decreased global DNA methylation. Global DNA methylation of 
the human colon cancer cell line HCT116 was studied. Wildtype (WT) cells and DNMT1−/− cells were utilized. 
DNA methylation was examined using 5mC fluorescence staining and a 5mC ELISA (Fig. 1). Qualitative dif-
ferences between WT and DNMT1−/− cells were identified within the nuclei, showing various 5mC-expressing 
foci in the WT cells (Fig. 1a; white arrows). When focusing on the overall fluorescence intensity of the entire 
cell nucleus, no significant difference in gray value intensity (GVI) per cell was detected (p = 0.914) (Fig. 1b). 
However, analysis of the subnuclear localization patterns showed a significant increase of 5mC-foci within the 
cell nuclei of WT cells when compared with DNMT1−/− cells (p < 0.05) (Fig. 1c). 5mC ELISA analysis exhibited 
a statistically significant 0.6% decrease in global DNA methylation in the DNMT1−/− cells when compared to 
WT cells (Fig. 1d; p < 0.05). In the WT cells, 1.4% of all cytosines were methylated, whereas the DNMT1−/− cells 
contained only 0.8% methylated cytosines (Fig. 1d).
Raman analysis of WT and DNMT1−/− cells shows differences in nucleic acid bands. The Raman 
spectral signature of the HCT116 WT cells displayed a cellular peak pattern consisting of complex overlapping 
signals from the biochemical cellular components (Fig. 2a,i). DNMT1−/− cells revealed an increased relative 
Raman signal at 830 cm−1 and decreased relative spectral intensities at the Raman bands 786 cm−1, 1257 cm−1, 
1330 cm−1, 1342 cm−1, 1579 cm−1, 1610 cm−1 and 1662 cm−1 (Fig. 2a,ii). Statistical analysis showed a significant 
change in intensity at 1257 cm−1 (p < 0.001), 1330 cm−1 (p < 0.01) and 1579 cm−1 (p < 0.001) (Fig. 2b).
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For further analysis of the spectral data, PCA was performed. PCA is commonly used to resolve complex spec-
tral peak shifts and to reveal spectroscopic variations and peak correlations by calculating principal components 
(PCs), which dissolve the variances within the spectra data set32,33. In the score plot (Fig. 2c), every data point 
represents a Raman spectrum of a single cell. The score values were used to validate significant differences in the 
Raman spectra of WT cells and DNMT1−/− cells. In the PC 4 scores plot, which describes 3% of the total spectral 
variances, WT cells and DNMT1−/− cells showed a separation tendency. Statistical analysis revealed significant 
differences of the PC 4 score value between WT and DNMT1−/− cells (p < 0.001) (Fig. 2c). Other PC scores 
did not show significant differences (Suppl. Fig. 3). In general, loadings of each PC demonstrate the spectral 
changes, which determine the position of the PC score values33. Positive peaks in the loadings indicate increased 
Raman signals in the original spectra of the positive score values. In contrast, negative loading values represent 
increased Raman signals in the spectra of the negative score values33. Based on the PC 4 loading, increased bands 
at 786 cm−1, 1257 cm−1, 1330 cm−1 and 1579 cm−1 were identified in the spectra of WT cells (Fig. 2d, arrows). 
DNMT1−/− cells showed an increased Raman signal at 1445 cm−1. However, the loading was quite noisy, which 
indicates that only slight differences of the Raman signals characterize the PC 4. Loadings of PC 1, 2 and 3 showed 
mostly the spectral baseline (Suppl. Fig. 3).
2i medium-adapted mESCs retain their pluripotency and show a significant global demethyl-
ation of genomic DNA. In order to reduce global DNA methylation, mESCs were adapted to serum-free 
2i medium (2i mESCs) as previously described31. Before DNA methylation analysis, the pluripotency of the 
Figure 1. Investigation of global DNA methylation in HCT116 WT and DNMT1−/− cells. (a) 
Immunofluorescence staining of 5-methylcytosine (5mC) in WT and DNMT1−/− cells. WT cells show various 
dense 5mC-foci within the nucleus indicated by white arrows. Scale bars equal 20 µm. (b,c) Semi-quantitative 
fluorescence intensity analysis of 5mC-stained cells. WT cells show significant more 5mC-foci/cell than 
DNMT1−/− cells. Two-tailed t-test, n = 3. (d) Global 5mC level in WT cells are significantly higher than in 
DNMT1−/− cells. Two-tailed t-test, n = 3.
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control and 2i mESCs was verified via Nanog and Oct4 protein expression by IF staining (Suppl. Fig. 2). As 
expected, both control and 2i mESCs showed Nanog and Oct4 protein expression (Suppl. Fig. 2a and b); however, 
semi-quantitative analysis of fluorescence intensities revealed a significantly higher Nanog expression in mESCs 
cultured in 2i medium when compared with the ESCs that were cultured in serum-containing control medium 
(Suppl. Fig. 2a). In addition, Nanog gene expression of 2i mESCs was 3-fold higher (p < 0.05) compared to the 
control mESCs, and Oct4 gene expression of 2i mESCs was 2-fold higher compared to control mESCs (Suppl. 
Fig. 2c).
mESC adaption to serum-free 2i medium results in a massive global demethylation of the genomic DNA34,35. 
For the determination of global DNA methylation levels in control versus 2i mESCs, a 5mC ELISA was performed 
revealing a significantly decreased relative cytosine 5mC of 4% (4.7% in control mESCs before adaption and 
0.7% in 2i mESCs after adaption) (Fig. 3a; p < 0.001). This result was confirmed by 5mC IF staining (Fig. 3b). 
The semi-quantitative fluorescence intensity analysis of the whole nucleus exhibited significantly lower GVI per 
colony in the 2i mESCs when compared with the control mESCs (Fig. 3c). By comparing subnuclear localization 
patterns of 5mC, we further identified that the control mESCs exhibited significantly more 5mC-foci within each 
cell nucleus (Fig. 3b, white arrows, and Fig. 3d).
Figure 2. Identification of DNA methylation Raman signatures in WT and DNMT1−/− cells. (a) Raman spectra 
of (i) HCT116 WT and (ii) DNMT1−/− cells. Raman signatures that can be assigned to DNA bands are indicated 
by arrows. Standard deviations are indicated by the gray lines. n = 125. (b) Statistical analysis of significantly 
increased Raman bands, which can be assigned to DNA methylation. (c) Score plot of PC 1 and PC 4 shows a 
grouping tendency between WT and DNMT1−/− cells illustrated by a gray arrow. The score mean value of both 
groups for PC 4 differs significantly from each other. Two-tailed t-test, n = 125 (d) PC 4 Loading describes the 
Raman shifts that vary in WT cells compared to DNMT1−/− cells. Noticeable DNA peaks are indicated by arrows.
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Raman microspectroscopy revealed altered nucleic acid signals in 2i medium-adapted 
mESCs. Control mESCs and 2i mESCs were investigated with Raman microspectroscopy. Non-stained con-
trol and 2i mESCs showed defined peak patterns containing complex overlapping signals from lipids, proteins, 
carbohydrates and nucleic acids36. Several differences in relative intensities between control mESCs (Fig. 4a,i) 
and 2i mESCs (Fig. 4a,ii) were identified. The most prominent ones, which can be assigned to nucleic acid bands, 
are highlighted with black arrows (Fig. 4a). Most prominent increased Raman bands in control mESCs were 
detected at 1257 cm−1, 1331 cm−1, 1379 cm−1 and 1575 cm−1. 2i mESCs exhibited an increasing relative inten-
sity at 818 cm−1. Statistical significant decreased Raman shifts were identified at 1257 cm−1 (p < 0.01), 1331 cm−1 
(p < 0.001) and 1575 cm−1 (p < 0.001) (Fig. 4b). The corresponding PCA analysis showed separated clusters for 
control and 2i mESCs in PC 4, which explained 3% of the total spectral variance. The PC 4 score values of control 
and 2i mESCs differed significantly (p < 0.001) (Fig. 4c). The corresponding loading of PC 4 showed decreased 
Raman bands (786 cm−1, 896 cm−1, 1257 cm−1, 1331 cm−1) and increased signals (481 cm−1, 1441 cm−1) for 2i 
mESCs when compared to control mESCs. In general, we noted that the loadings were quite noisy, which indi-
cates that only slight differences of the Raman signals characterize the PC 4 (Fig. 4d). For the other PC scores, no 
separation tendency was detected. Scores and loadings of PC 1–3 are shown in Suppl. Fig. 4.
Raman spectra differentiate between low and high methylation status independent of the cell 
type. To further investigate whether the differences in Raman spectra of the low and high global DNA meth-
ylation status are independent of species and cell types, PCA were performed on the whole data sets consisting of 
the spectra from all, the mESCs (control and 2i mESCs) and human colon cancer (HCT116 WT and DNMT1−/−) 
cells. A 3D score plot of PC 2 (12%), PC 4 (3%) and PC 5 (2%) revealed separations between the samples (Fig. 5a). 
Figure 3. Investigation of global DNA methylation changes. (a) 5mC expression in mESCs cultured under 
control conditions or in 2i medium. 2i medium-adapted cells show a significantly lower DNA methylation. 
Two-tailed t-test, n = 3. (b) Immunofluorescence staining of 5mC. Scale bars equal 20 µm. (c + d) Quantitative 
fluorescence intensity analysis of 5mC-stained mESCs. 2i medium-cultured mESCs show a significant lower 
mean intensity and less 5mC-foci/cell (indicated by white arrows in b) when compared with cells cultured in the 
presence of serum (control). Two-tailed t-test, n = 3.
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PC 2 reflects differences between cell types and separates between mESC as well as the WT and DNMT1−/− cells. 
In addition, PC 5 revealed a separation tendency between the high-methylated mESC control and the HCT116 
WT cells, and the low-methylated 2i mESC and DNMT1−/− cells. This separation is also illustrated in Fig. 5b, 
showing the mean score values of PC 5. The score values of the control mESCs differed significantly from the 
score values of the 2i mESCs (p < 0.001), and the score values of the HCT116 WT cells differed significantly from 
the score values of the DNMT1−/− (p < 0.01).
The most prominent Raman peaks that revealed altered relative intensities in Raman spectra of the high- 
and low-methylated mESCs and the high- and low-methylated human colon cancer WT and DNMT1−/− cells 
are summarized in Table 1. Most of them show increased signals for high level of DNA methylation (786 cm−1, 
1257 cm−1, 1317–1323 cm−1, 1335 cm−1, 1342 cm−1, 1379 cm−1, 1579 cm−1, 1605–1610 cm−1and 1662 cm−1). The 
Raman band at 815–830 cm−1 revealed a decreased relative intensity in the high-methylated cells.
Raman imaging identifies 5mC-foci on a subnuclear level. Since the differences in the Raman spec-
tra between the investigated groups were rather subtle, high-resolution Raman imaging was additionally per-
formed to obtain laterally-resolved spectral information of the 5mC–foci within the cell nuclei. HCT16 WT 
Figure 4. Identification of mESC Raman signatures due to an altered global DNA methylation. (a) Raman 
spectra of mESCs cultured in (i) control and (ii) 2i medium. Raman signatures that can be assigned to DNA 
bands are indicated by black arrows. The standard deviation is indicated by the gray lines. (b) Statistical analysis 
of significantly increased Raman bands, which can be assigned to DNA methylation. Two-tailed t-test, n = 85. 
(c) Score plot of PC 1 and PC 3 shows a grouping tendency of mESCs cultured in control and 2i media. The 
direction of the gray arrow indicates the loss of DNA methylation. The score mean value of both groups for PC 
4 differs significantly from each other. Two-tailed t-test, n = 85 (d) PC 4 loading describes the Raman shifts 
that vary in 2i-adapted mESCs compared with mESCs cultured in the control medium. Peaks of interest are 
indicated by black arrows.
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Figure 5. Comparison of Raman spectra from mouse pluripotent stem cells cultured in either control or 2i 
medium with human colon cancer WT and DNMT−/− cells. (a) 3D score plot of Raman spectra from control 
mESCs, 2i mESCs as well as human colon cancer WT and DNMT1−/− cells showing PC 2, PC 4 and PC 5. There 
is a grouping tendency between control mESCs and WT cells (blue shades), as well as 2i mESCs, DNMT1−/− 
cells (green shades). (b) The grouping tendency is visualized by a box plot of PC 5 score values. It shows 
significantly lower scores for control mESCs and WT cells when compared with 2i mESC and DNMT1−/− cells. 
One-way ANOVA, n = 30.
Raman Shift (cm−1) Assignment
↑↓ relative Raman 
intensity for high-
methylated cells
786 5-Methylcytosine
52, Cytosine, Thymine, 
Phosphate backbone of DNA/RNA39,47–49 ↑
815–830 Phosphate backbone of DNA/RNA54 ↓
1257 Cytosine, Adenine38,41 ↑
1317–1323 Guanine41,47 ↑
1335 CH2CH3 wagging37 ↑
1342 Guanine47 ↑
1379/1386 CH339,53 ↑
1579 Pyrimidine ring39 ↑
1605–1610 Cytosine41 ↑
1662 DNA58,59 ↑
Table 1. Identified Raman peaks that are altered due to global DNA methylation in mESCs and human colon 
cancer cells.
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and DNMT1−/− cells (Fig. 6a–d) as well as control and 2i mESCs (Fig. 6e–h) were scanned with a resolution of 
0.2 × 0.2 µm. A heat map of both cell types was created using the sum of the intensities at 1257 cm−1, 1331 cm−1 
and 1579 cm−1. The heat maps of the resulting Raman images showed specific structures within the nucleus that 
were comparable to the structures seen when performing 5mC IF staining (Fig. 6a,b,e,f). In the average spec-
tra from high-intensity (highly methylated) regions and low-intensity (background) regions of the heat maps, 
increased Raman peaks in the spectral region of 1250–1390 cm−1 were observed for both cell types (Fig. 6c,g). The 
semi-quantitative pixel intensity analysis of the heat maps exhibited significantly lower values for the HCT116 
DNMT1−/− cells and 2i mESCs when compared with the HCT116 WT cells and control mESCs (Fig. 6d,h; 
p < 0.05).
Discussion
It this study, we demonstrated that Raman microspectroscopy and Raman imaging have the potential to detect 
DNA methylation states in living cells. We utilized different cell types from human and mouse origin that differ 
in their global DNA methylation level, and identified specific Raman signals that can be employed to monitor 
methylated DNA in situ.
In a first step, by measuring 5mC and methylated DNA, we identified specific Raman bands at 1257 cm−1, 
1335 cm−1, 1379 cm−1 and 1579 cm−1 that can be assigned to nucleobases or CH3 (Table 1)37–41. These results 
demonstrate that differences between methylated and non-methylated DNA can be detected by Raman 
microspectroscopy.
Next, we used WT cells of the human colon cancer cell line HCT116 and their DNMT1-hypomorph progeny 
showing a lower global DNA methylation. We confirmed the decreased global DNA methylation in DNMT1−/− 
cells by anti-5mC IF staining and 5mC ELISA. Interestingly, in our study, in both the WT and DNMT1−/− cells, 
the 5mC ELISA revealed a lower global DNA methylation level when compared to previous studies30. Literature 
determined 4.0% methylated cytosines for WT cells, and our results revealed 1.3%. For DNMT1−/− cells, 
3.2% of all cytosines were reported to be methylated30. In our study, we quantified 0.7% methylated cytosines. 
Nevertheless, the relative global DNA methylation difference of 0.6% between the samples is similar to what had 
been previously reported30.
Our Raman microspectroscopy measurements showed differences in the Raman signatures of WT and 
DNMT1−/− cells. PCA revealed a grouping tendency for PC 4 (Fig. 2). Although some overlapping of the popu-
lations was seen that might be due to biological variances within the samples, the mean score values revealed a 
significant difference between the two samples. Most differences in Raman spectra as well as striking peaks in the 
loading plot could be assigned to nucleic acid bands (Table 1).
The second cell type in this study were mESCs that were either maintained in routine serum-containing con-
trol medium, or they were adapted to serum-free 2i medium. As expected, exposure to 2i medium led to massive 
global DNA demethylation as described before31,34,35, which was successfully confirmed by anti-5mC IF stain-
ing and 5mC ELISA. Accordingly, the control mESCs revealed a global DNA methylation of 4%34,35, and only 
1% of all cytosines were methylated in the 2i medium-adapted mESCs34. We confirmed that the mESCs main-
tained their pluripotency after 2i adaption by gene and protein expression profiling focusing on the pluripotency 
markers Nanog and Oct4, which were increased after two weeks of 2i medium adaption. This observation is 
conform with a report by Ying et al. who postulated that 2i ESCs represent the ground state of pluripotency31. 
Therefore, we hypothesize that the 2i mESCs used in our study were actually closer to the “naïve pluripotent 
ground state” than mESCs cultured in standard serum-containing medium31,42. However, the adaption process 
of mESCs to serum-free 2i medium seems to be not homogenous and may require modified culture protocols. 
The gene expression of the pluripotency markers Nanog and Oct4 (Suppl. Fig. 2) as well as the 5mC fluorescence 
signal (Fig. 3) revealed high variances within the 2i mESC population. Interestingly, Abranches et al. made sim-
ilar observations showing higher Nanog fluctuations in cells that were exposed to 2i medium43. One explanation 
for this could be that some of the cells in our population were already differentiated prior exposure to the 2i 
medium. Tamm et al. examined the capacity of 2i medium to rescue partially-differentiated mESCs by culturing 
spontaneously-differentiated cells in 2i medium44. They found that the cells were not able to return to the ground 
state anymore44.
Employing Raman microspectroscopy, we were able to distinguish between 2i medium-adapted and control 
mESCs. Overlapping populations in PC 4 can be explained by biological variances within the samples due to the 
heterogeneity of the 2i mESC population as described above. The most prominent Raman bands, which revealed 
the major differences, were assigned to nucleic acid bands and methyl groups (Table 1). DNA methylation and 
remodeling of chromatin are the most striking changes during early embryogenesis8–10,45. It can therefore be 
assumed that the DNA methylation level represents a potential biomarker that can be tracked during early embry-
onic development. Nevertheless, it must be taken into account that the 2i medium-treated mESCs used in our 
model system may also show other epigenetic changes, e.g. a reduction of H3K27me346.
In all experiments of this study, we detected altered relative peak intensities in the Raman spectra of cells 
with different DNA methylation levels. Most of the Raman shifts were assignable to DNA components, nucle-
obases, phosphate and ribose. We identified marker peaks, which can be assigned to 5mC, such as the Raman 
shift at 786 cm−1. This peak is also associated with cytosine, thymine or phosphate41,47–51. However, Barhoumi 
et al. described the appearance of a peak in case of 5mC at the same position52. The comparison of the loadings 
from both cell types in our study revealed a higher relative intensity at 786 cm−1 for the cells with a higher DNA 
methylation (human colon cancer WT cells and control mESCs). A further peak at 1330–1331 cm−1, which can 
be assigned to CH3 and CH3CH2 twisting and wagging modes in nucleic acids, was observed for all highly methyl-
ated cells as well as for 5mC and methylated DNA39,53,54. In addition, an increased peak between the wavenumbers 
1379 cm−1 and 1386 cm−1, also shown in the Raman spectra of methylated DNA, was detected in the spectra of 
control mESCs. In this region, previous studies described symmetric CH3 bending39,53.
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In addition to 5mC markers, we observed changes in DNA signals which might be an indirect effect of 5mC. 
Most predominant peaks that cannot directly be assigned to 5mC but to other nucleobases and potential chroma-
tin changes were observed at 1257 cm−1 (thymine, cytosine, adenine)41,48,49,55, 1304 cm−1 28,39 (cytosine, adenine)56, 
Figure 6. Detection of 5mC-foci with high-resolution Raman imaging of HCT116 cells and mESCs. (a) Anti-
5mC immunofluorescence staining of HCT116 WT and DNMT1−/− cells. (b) Heat maps of the Raman images 
obtained from HCT116 WT and DNMT1−/− cells using the sum intensities of 1257 cm−1, 1379 cm−1 and 
1579 cm−1. (c) Average spectra from high-intensity regions and low-intensity regions of the heat maps from 
panel (b). (d,h) Statistical analysis of the Raman images from panels b and f. Two-tailed t-test, n = 3. (e) Anti-
5mC immunofluorescence staining of mESC control and 2i mESCs. (f) Heat maps of the Raman images from 
mESC control and 2i mESCs using the sum intensities described in panel b. (g) Average spectra from high-
intensity regions and low-intensity regions of the heat maps from panel f. Scale bars in all images equal 5 µm.
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1323 cm−1 (guanine)57, 1579 cm−1 (pyrimidine ring)39 and 1662 cm−1 (amide I, nucleic acid modes)58,59. These 
peaks were also detected in the loadings of the corresponding PCs for the compared cell types. In addition, 
the Raman peaks at 1257 cm−1 and 1579 cm−1 were also observed in the spectra of methylated DNA. It is still 
unclear why methylated DNA seems to enhance nucleobase-assigned Raman shifts. A possible explanation for 
the enhanced Raman shift of thymine could be that it is, similar to cytosine, a pyrimidine ring39,47,60. Due to the 
additional methyl group at C5, the 5mC has a very similar chemical structure when compared to the thymine61. 
Raman signals for 5mC might therefore appear at the same positions as those described previously for thymine.
We analyzed the Raman images of the HCT116 cells and mESCs. Using the sum of the intensities at 1257 cm−1, 
1331 cm−1 and 1579 cm−1, a heat map of the Raman images from both cell types was generated. We were able to 
show a significant intensity increase in the heat maps of the mESC control and HCT116 WT cells when compared 
with the mESC 2i and HCT116 DNMT1−/− cells (Fig. 6d,h). In addition, the heat maps revealed structures within 
the nuclei that were similar to the 5mC-foci identified by the anti-5mC IF staining (Fig. 6b,f). These regions are 
likely to be composed of heterochromatin, since the DNA is densely packed here and thus generates a stronger 
Raman signal62. Since most of the DNA methylation-related consequences are genomic imprinting, DNA meth-
ylation is more strongly present in heterochromatic regions63, suggesting that the structures can be associated 
with DNA methylation. Based on our results, we hypothesize that the Raman bands at 1257 cm−1, 1331 cm−1 and 
1579 cm−1 are potential markers for DNA methylation.
The overall challenge of this study was to assess DNA methylation changes in situ, which represent only a 
small fraction of all the processes that take place at a certain time in a living cell. Not only the epigenome, but also 
the genome, transcriptome and proteome of a cell is subject to complex dynamic processes46. This might be one 
of the reasons why some of the detected changes were only minor. In order to obtain statistically even more valid 
data, more cell types could be included in further investigations, and direct methods for the elimination of DNA 
methylation such as DNMT 1/3a/3b trible KO could be used.
Conclusion
Our data demonstrate that Raman microspectroscopy and Raman imaging in combination with PCA possess the 
required fidelity to detect little but significant changes in DNA methylation status on a single cell level. Here, we 
employed these technologies to track epigenetic changes in mouse pluripotent stem and human colon cancer cells 
in situ. We also showed that high-resolution Raman imaging can resolve structures on a nano- and microscale 
within the nucleus of living cells enabling the monitoring of epigenetic processes. Raman microspectroscopy and 
Raman imaging may ultimately allow scientists to further decipher crucial connections between epigenetics and 
early human embryogenesis, aging or diseases.
Methods
Cell culture. Rhee et al. previously generated a HCT116 DNMT1 knockout construct in which exons 3, 4, 
and 5 of human DNMT1 were replaced with a hygromycin resistance gene. The disruption of DNMT1 led to 
a reduced global DNA methylation30. Human colon cancer HCT116 wildtype cells (ATCC® CCL-247™) and 
DNMT1−/− cells were cultured in RPMI medium 1640 (Thermo Fisher Scientific, Waltham, USA) with 10% FBS 
and 1% P/S.
CCE mESCs (ATCC® SCRC-1023™) were cultured in KO-DMEM (Thermo Fisher Scientific), supplemented 
with 15% fetal bovine serum, 1% Penicillin-Streptomycin, 1% MEM non-essential amino acids, 1% L-Glutamine, 
0.2% HEPES, 0.1% 2-Mercaptoethanol (all Thermo Fisher Scientific) and 0.1% Leukemia inhibitory factor 
(Merck, Darmstadt, Germany). Cells were split every second day. To obtain naïve mESCs, the cells were adapted 
to a serum-free culture condition using ESGRO®-2i Medium (Merck) according to the manufacturer’s protocol. 
The adaption took 14 days. Every second day, cells were split.
Immunofluorescence (IF) staining. IF staining was performed using a 5mC mouse monoclonal IgG anti-
body (Merck, MABE146) according to a previously described protocol64 with slight modifications. Cells were 
washed with PBS and fixed with 0.25% paraformaldehyde (Sigma-Aldrich, St. Louis, USA) in PBS− for 10 minutes 
at 37 °C, and 88% methanol at −20 °C for 30 minutes. After washing, the cells were treated with 1 M HCl at 30 °C 
for 30 minutes and were neutralized with 0.1 M sodium borate (pH 8.5). In order to reduce nonspecific binding, 
the cells were incubated with 2% goat block solution for 20 minutes at 37 °C. Afterwards, the cells were incu-
bated with the 5mC antibody (1:2000, stock 2 mg/ml) overnight at 4 °C. Finally, the cells were stained with goat 
anti-mouse IgG Alexa Fluor 488 (1:250, Thermo Fisher Scientific) for 30 minutes at room temperature in the dark. 
IF staining against Nanog and Oct4 (also known as POU5F1) was done as previously described65. As primary 
antibodies served Oct4 rabbit polyclonal IgG (1:200; ab19857, abcam, Cambridge, UK) and Nanog rabbit poly-
clonal IgG (1:100, NB100–588, Novus Biologicals, Littleton, USA). Goat anti-rabbit IgG-Alexa Fluor 488 (1:250, 
Thermo Fisher Scientific) was used as secondary antibody. DAPI (1:1, in DPBS, Roche Diagnostics, Mannheim, 
Germany) was used for nuclear staining. Imaging was done with an LSM 710 confocal microscope (Carl Zeiss 
AG, Oberkochen, Germany). ImageJ (NIH) was used for semi-quantitative fluorescence analyses.
Detection of global DNA methylation using 5mC ELISA. DNA was isolated using the FlexiGene® 
DNA Kit (Qiagen, Hilden, Germany) as instructed by the manufacturer. The 5mC DNA ELISA Kit (D5325, 
ZymoResearch, Irvine, USA) was used to quantify global DNA methylation. It is based on the colorimetric detec-
tion of 5mC using an anti-5mC antibody. The procedure was done according to the manufacturer’s protocol. The 
wells were loaded with 100 ng DNA. Absorbance was detected at 405 nm using an Infinite® 200 Pro microplate 
reader (Tecan Group AG, Männedorf, Switzerland). Levels of 5mC were calculated as the percentage of methyl-
ated cytosines in total DNA content based on a standard curve generated using the kit controls.
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Quantitative reverse transcription polymerase chain reaction (RT-qPCR). RNA was extracted 
from control and 2i mESC as well as primary-isolated mouse embryonic fibroblasts using RNeasy® Plus Mini Kit 
(Qiagen) following manufacturer’s protocol and stored at −80 °C prior further use. The amount and purity of the 
RNA were determined by NanoDrop 2000 spectral photometer analysis (Thermo Scientific). A total amount of 
1 µg RNA was used to synthesize cDNA utilizing a transcriptor first strand cDNA synthesis kit (Roche). RT-qPCR 
was carried out using a QuantiTect SYBR Green PCR kit for mESCs (Qiagen). cDNA was used in qPCR reactions 
with Nanog and Oct4 primers (Qiagen). The samples were normalized to the housekeeping gene Gapdh (Qiagen). 
All procedures were performed as instructed by the manufacturer. For the quantification of the qPCR data, the 
ΔΔCt was used to determine fold change in RNA expression patterns.
Raman microspectroscopy of cytidine, 5mC, methylated and non-methylated DNA stand-
ard. Cytidine, 5mC (Sigma Aldrich, St. Louis, USA) as well as methylated and non-methylated DNA standards 
(D5325-5-1, D5325-5-2, ZymoResearch, Irvine, USA) were measured with a confocal Raman microspectroscope 
(alpha300R, WiTEC GmbH, Ulm, Germany). Raman spectra were acquired with a 50x air objective (N.A. 0.55; 
Carl Zeiss GmbH, Jena, Germany), using an excitation wavelength of 532 nm, a laser power of 60 mW and an 
acquisition time of one second.
Raman microspectroscopy of single living cells. A custom-built Raman microscope as previously 
described65–67 was employed for measuring single living cells. The device consists of a near-infrared 784 nm diode 
laser with a maximum output power of 85 mW, which was integrated into a standard fluorescence microscope 
(IX71, Olympus, Japan). A 60x water immersion objective (Olympus®) with a 1.2 numerical aperture (NA) was 
used for the Raman measurements, resulting in a laser spot in approximately 1 µm diameter68. Spectra were 
detected using an air-cooled charge couple device camera (Andor, Belfast, UK). All cells were trypsinized using 
0.25% Trypsin-EDTA (Thermo Fisher Scientific), centrifuged and resuspended in PBS, and transferred to a glas 
bottom petri dish (Ibidi, Martinsried, Germany). For each sample, 90 single living cells were measured using 
10 accumulations, each 10 seconds. The laser was focused on the center of each cell due to an optical trapping 
effect69. The laser focus targets automatically the densest organelle of each cell, which was previously shown to be 
the cell nucleus70. A reference spectrum of the background (glass bottom petri dish covered with PBS) was taken 
after every ten cells.
Analysis of Raman spectra. Details on the pre-processing steps were published previously in detail65,68. 
Pre-treatment of the Raman spectra (background subtraction and baseline correction) was performed using 
the OPUS 4.2 software (Bruker, Ettlingen, Germany). The spectra were cut from the range of 0–1,935 cm−1 to 
400–1,800 cm−1. In order to perform a PCA, the pre-treated data was imported to the Unscrambler X 14.0 soft-
ware (Camo Software, Oslo, Norway). Vector normalization (normalized to length 1) was applied on the spectra. 
Afterwards, a PCA analysis with up to 7 principal components (PCs) was performed. The PCA results were pre-
sented in a scores plot and loading plots. To compare cells with high versus low methylation levels, confidence 
ellipses were calculated using the software Origin Pro 9.1 (OriginLab, Northampton, USA).
Raman imaging of mESCs and HCT116 cells. For Raman imaging of cells, the confocal Raman 
microspectroscope alpha300R (WITec GmbH, Ulm, Germany) was employed. mESCs and HCT116 cells were 
trypsinized using 0.25% Trypsin-EDTA (Thermo Fisher Scientific), centrifuged and resuspended in PBS. Cells 
were immobilized on a glass slide using the Shandon Cytospin 3 (Thermo Fisher Scientific). The cytospots were 
dried for 20 min and stored at −20 °C. Prior to Raman imaging, the cells were IF-stained using an antibody 
against 5mC as described above. Raman images were acquired with a 63x Apochromat water dipping objective 
(N.A. 1.0; Carl Zeiss GmbH, Jena, Germany). Cells were located and an area of 15 × 15 µm was imaged using a 
step size of 0.2 µm. A green laser with an excitation wavelength of 532 nm was used. The laser power was set on 
60 mW and the acquisition time was 0.5 seconds. mESCs obtained from the control and 2i cultures and HTC WT 
and DNMT1−/− cells were imaged and compared. Raman images were analyzed using the Project Five 5.1 Plus 
software (WITec GmbH). A cosmic ray removal and a baseline correction was employed prior to analysis. In 
order to generate a heat map of selected Raman signals, intensity sum filters for the respective Raman bands were 
created and summed up. Semi-quantitative analysis of the heat maps was performed with ImageJ.
Statistical analysis. Except stated otherwise, data are shown in mean ± standard deviation (SD). One-way 
analysis of variance (ANOVA) was performed to compare data groups. Student’s t-test was performed to compare 
between two data groups using OriginPro (OriginLab®). Probability values of 95%, 99% and 99.9% (p < 0.05, 
0.01, 0.001) were used to determine significance.
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